Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Temporal triangular alopecia is a lifelong condition with hairless patches on the side of the head that may be present from birth.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Transferrin receptor 1 is essential for normal function in the intestines, pancreas, and skin.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Most cases of Temporal Triangular Alopecia are found in early childhood and may be related to genetic conditions.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

People with alopecia areata have higher levels of a heart disease marker in their blood.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

TIP39 and PTH2R help control calcium levels and skin cell development.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

The study found that Tourette Syndrome may be linked to certain immune system processes and synaptic signaling.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.